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Immune-mediated necrotizing myopathy is a rare and
recently described form of idiopathic inflammatory myopa-
thy, characterized as a necrotizing myopathy with minimal or
no inflammatory infiltrate on muscle biopsy. The clinical fea-
tures of symmetrical proximal muscle weakness and acute or
subacute onset may be misunderstood with polymyositis or
dermatomyositis. This condition has a wide range of reported
outcomes, from fast progression with no remission to com-
plete recovery. To the best of our knowledge up to date there
is no case reported in Brazil of immune-mediated necrotizing
myopathy, and no one in Latin America related to cancer. Here
we  described a case of paraneoplastic necrotizing myopathy
secondary a tubo-ovarian adenocarcinoma.Case  report
A 61-year-old woman, married, white, was admitted with
the chief complaint of pain and progressive weakness of the
lower limbs, with ascension to upper members, of 4 weeks of
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licenses/by-nc-nd/4.0/).development, associated with dysphagia and dysphonia. She
also reported weight loss of 10 kg in that period. She previ-
ously had hypertension and hypothyroidism. She underwent
a total hysterectomy 21 years ago due to uterine leiomyomato-
sis. She also underwent bariatric surgery, abdominoplasty and
mammaplasty for about 9 years. There was no history of alco-
holism, smoking or use of recreational drugs. The family his-
tory was positive for acute myocardial infarction and stroke.
On physical examination the patient was afebrile and
appeared well. The pulse was 68 bpm, the blood pressure
130 × 85 mmHg, breathing frequency of 20 incursions per
minute. The lungs and heart were normal. There was a pres-
ence of a median scar on abdomen. Edema of lower limbs and
plastering of calves were absent. Neurological examination
showed a weakness of proximal muscles graduated in 2 and
weakness of distal muscles graduated in 4 on a scale of 0–5.
The deep tendon reflexes were graduated in 1 on a scale of 0–4.
The plantar cutaneous reflex was in flexion bilaterally. There
were no other abnormalities on neurological examination.
Additional laboratory evaluation showed a creatine kinase
of 7874 U/l (normal range: 26–192), lactic acid dehydrogenase
1350 U/l (reference: <50), aspartate aminotransferase 452 U/l
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Fig. 1 – Necrosis with macrophagy (asterisk), nuclear
centralization (arrowhead), regenerating fibers (arrows) and
atrophic fiber (circle), in the absence of inflammatory
infiltrate. HE X250. Given by Dr. Beny Schmidt, associate
professor of pathological anatomy, chief of the
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Fig. 2 – Filling defects of segmental branches of the right
lower lobe and left lower lobe due to pulmonaryeuromuscular Laboratory – UNIFESP.
<32), alanine aminotransferase 679 U/l (<33). Serological tests
or hepatitis B and C and for HIV were negative. In immuno-
ogical parameters, the antinuclear factor was positive with
 speckled pattern, titer of 1/160, but anti-JO and anti-
ative DNA antibody, anti-ribonucleoprotein, anti-Ro, anti-La,
nti-SCL70 were negative. Cerebrospinal fluid analysis was
ositive for neoplastic cells. The level of CA125 was increased:
013 U/mL (reference: <35).
Electromyography showed a pattern of predominantly
roximal myopathy, polyphasic motor unit potentials reduced
n amplitude and duration. Biopsy of the deltoid muscle
evealed atrophy of muscle fibers, with homogeneous necrosis
nd the presence of macrophagy, with absence of inflam-
atory infiltrate (Fig. 1). The search for malignancies of
astrointestinal tract by upper gastrointestinal endoscopy
nd colonoscopy resulted negative. Screening for breast can-
er with mammography and research of tumor marker CA
5.3 was negative. Computed tomography (CT) of the chest
howed bilateral pulmonary thromboembolism, reinforcing
he idea of underlying malignancy neoplasia (Fig. 2). A CT
f the abdomen and pelvis showed retroperitoneal lym-
hadenopathy involving the chain interaortocaval, pelvic
ymphadenopathy and lymphonodes around the bladder. MRI
f the abdomen and pelvis showed the presence of retroperi-
oneal node 6 centimeters of larger diameter and the presence
f vascularized solid nodule in the right ovary. Magnetic reso-
ance imaging of the skull and spine showed no neoplastic
ocus. White matter of the brain hemispheres had foci of
schemia, while column showed degenerative changes, as well
s atrophy of the posterior paraspinal muscle groups, with
eplacement of muscle fibers by fat, especially in the lumbar
pine.
The biopsy of the retroperitoneal mass showed adenocar-
inoma infiltration. The patient then underwent exploratory
aparotomy with bilateral oophorectomy, resection ofthromboembolism.
paraaortic mass, omentectomy and pelvic lymphadenec-
tomy. The study by immunohistochemistry concluded that
it was a right tubo-ovarian high-grade serous carcinoma
with metastasis to the left ovary, periaortic lymphonodes and
omentum. The patient died 2 weeks after surgery due to sepsis
after severe pancytopenia, possibly due to neoplastic marrow
infiltration, although bone marrow biopsy for confirmation
was not performed.
Discussion
Immune-mediated necrotizing myopathy is now recognized
as part of the group of Idiopatic Inflammatory Myopathies
that include polymyositis, dermatomyositis, sporadic inclu-
sion body myositis, juvenile dermatomyositis and amyopathic
and hypomyopathic dermatomyositis. This uncommon condi-
tion is frequently confused with polymyositis because of their
symptoms of weakness of proximal muscles and high levels
of creatine kinase.1 It may occur in several settings, includ-
ing viruses, connective tissue diseases, in association with the
use of certain drugs, including statins and as a paraneoplastic
disorder.
The Immune-mediated necrotizing myopathy that occurs
in association with use of statins persists despite drug dis-
continuation, unlike the more  typical statin-related myopathy
that resolves after drug discontinuation. In comparison to the
toxic myopathy, the course of a necrotizing myopathy may
be self-limited, and recovery may occur after the offending
agent is discontinued, occasionally over weeks to months.
Like polymyositis and dermatomyositis, it may precede the
identification of a tumor. The most common cancers are
gastrointestinal tumors, small cell lung cancer, and breast
cancer.2
These patients may have high elevations of creatine kinase
levels, greater than 10 times the upper limits of normal, with
acute or subacute onset of symptoms, although a chronic
disease course may also occur. In the physical examination
1proximal muscle weakness is found. As with other idio-
pathic inflammatory myopathies, electromyography should
be performed to confirm a myopathic process characterized by
polyphasic motor unit action potentials of short duration and
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low amplitude with increased insertional and spontaneous
activity with fibrillation potentials, sharp waves, or repetitive
discharges and to target a muscle for biopsy. It is recom-
mended that the same muscle on the opposite side should
be chosen for biopsy.1
The pathophysiology of this disease is still incom-
pletely understood. Statin-induced necrotizing myopathy has
been associated with an antibody against the 3-hydroxy-3-
methylglutaryl-coenzyme A reductase (HMGCR) protein that
is upregulated in regenerating muscle fibers.1 T cell-mediated
immune responses as well as humoral factors may be
involved. The small number of inflammatory cells in muscle
specimens of patients with necrotizing myopathy raises the
possibility of a toxic molecule mediating the syndrome, but
the response to steroids or immunoglobulins is more  compat-
ible with an immune-mediated process.3
Histopathologically, in paraneoplastic necrotizing
myopathies an heterogeneous pattern of necrosis are found,
ranging from sparse, segmental necrotic lesions to massive
necrosis.2,4,5 Macrophages surround necrotic muscle fibers,
and atrophic and regenerating fibers are present. Immuno-
staining reveals Tlymphocytes (CD3) and macrophages (CD68)
around necrotic and regenerating muscle fibers.1
Despite the new evidences, it has recently been shown
how rheumatologists and neurologists often differ in clas-
sification of myopathies. While neurologists are specialized
in diagnosis utilizing electromyography and muscle biopsy
interpretation, rheumatologists, on the contrary, are typi-
cally trained in making a clinical diagnosis, understanding
the role of autoantibody association.6 Nevertheless, effective
communication and synergy between subspecialists, using
both strategies to make diagnosis and to classify, is nowadays
required to improve communication and achieve consistent
conclusion in clinical trials.
Conclusion
Immune-mediated necrotizing myopathy secondary to statin
7has already been reported in Latin America by Opazo et al, but
until our present knowledge this is the first case of immune-
mediated necrotizing myopathy reported in Brazil and the first
related to neoplasia in Latin America.
7 2 0 1 7;5 7(1):82–84
This case report emphasizes the need for clinical sus-
picion of cancer in patients with idiopathic inflammatory
myopathies and highlights the immune-mediated necrotizing
myopathy, one of its more  recently described clinical forms.
The case showed good correlation with what is found in the lit-
erature regarding the clinical manifestations. Ovarian cancer
is not the neoplasm most commonly found in paraneoplas-
tic necrotizing myopathies. Therefore, this case demonstrates
the need to investigate other sites beyond gastrointestinal,
lung and breast. The recovery of the symptoms of muscle
weakness after treatment of the underlying cancer could not
be assessed due to the advanced cancer stage of the patient.
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